Corline Biomedical AB (FRA:IZ7) Institutional Ownership: 0.02% (As of Aug. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:IZ7 Corline Biomedical AB FRA:IZ7
43 GF Score
Price €1.45
GF Value €0.79
! 4 Warning Signs
View Full Analysis

What is Corline Biomedical AB Institutional Ownership?

Corline Biomedical AB FRA:IZ7 -0.69% 43 Institutional Ownership is 0.02% as of Aug. 29, 2026. GuruFocus rates FRA:IZ7 with a GF Score™ of 43/100 and a GF Value™ of €0.79. The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Corline Biomedical AB's institutional ownership is 0.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Corline Biomedical AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Corline Biomedical AB's Float Percentage Of Total Shares Outstanding is 0.00%.

Corline Biomedical AB Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Corline Biomedical AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corline Biomedical AB Institutional Ownership Chart

Corline Biomedical AB Historical Data

The historical data trend for Corline Biomedical AB can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02
FRA:IZ7
43GF Score
Corline Biomedical AB FRA:IZ7
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Corline Biomedical AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.02% mean?
Corline Biomedical AB (FRA:IZ7) has a Institutional Ownership of 0.02% as of Aug. 29, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Corline Biomedical AB and its competitors.
Is Corline Biomedical AB's Institutional Ownership too high?
Corline Biomedical AB's current Institutional Ownership is 0.02%. Overall, Corline Biomedical AB has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Corline Biomedical AB's Institutional Ownership compare to VRTX and REGN?
Corline Biomedical AB's Institutional Ownership of 0.02% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Corline Biomedical AB and its competitors. Corline Biomedical AB's current Institutional Ownership is 0.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corline Biomedical AB stock overvalued right now?
Corline Biomedical AB (FRA:IZ7) has a current Institutional Ownership of 0.02%. The stock's GF Value™ is €0.79, compared to a current price of €1.45 — trading 82.9% above its estimated fair value. The current Institutional Ownership is 0.02%. Corline Biomedical AB's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Corline Biomedical AB (FRA:IZ7), the current Institutional Ownership is 0.02% as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Corline Biomedical AB (FRA:IZ7) Overvalued in 2026?

Based on GuruFocus' analysis, Corline Biomedical AB stock appears to be overvalued. The current stock price of €1.45 is trading 82.9% above its estimated GF Value™ of €0.79.

Key valuation signals for FRA:IZ7:

  • Institutional Ownership: 0.02%
  • GF Value™: €0.79 vs. price of €1.45 (82.9% above fair value)
  • GF Score™: 43/100 with 4 warning signs

No single metric tells the full story. See the FRA:IZ7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Corline Biomedical AB Business Description

Other Exchanges CLBIO:Sweden
Address Lefflersgatan 5, Uppsala, SWE, 754 50
Corline Biomedical AB offers customers in the medical technology industry and regenerative medicine as well as transplant clinics products to manage immune thrombosis. The company offers a proprietary surface treatment technology, Corline Heparin Surface (CHS), which can be used in combination with all commonly used implant materials such as polymers (plastics) and various metals, but also for equipment where blood circulation occurs outside the body.
43GF Score

Get the complete analysis for FRA:IZ7

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.45
Price
€0.79
GF Value